Brooks Laboratories Ltd.
•₹ 60-0.5%
2026-08-21
PROS
- Company is almost debt free
- Operating margins have improved to 8.2% from -41.5%
- Company comfortably covers its interest (30.4x coverage)
CONS
- Company has a low return on capital employed of -4.4%
- Company has a low return on equity of -6.0% over last 3 years
- Promoter holding has decreased over last 2 years: -11.0pp
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.43x)
- Contingent liabilities are large at 100.2% of net worth
- Effective tax rate is unusually low at 0.0% - earnings may be flattered
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 3620.70 | 2139.42 | 20263.10 | 1191.00 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | BROOKS | 59.50 | 13.27 | 175.27 | 0.00 | -1.79 | -101.86 | 22.96 | -9.99 | 21.72 | -5.85 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16 | 24 | 22 | 18 | 18 | 21 | 21 | 23 | 26 | 23 | 17 | 20 | 23 | |
| 16 | 23 | 21 | 17 | 18 | 19 | 19 | 22 | 22 | 21 | 16 | 20 | 22 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -1 | 1 | 1 | 0 | -0 | 1 | 1 | 2 | 3 | 2 | 0 | 1 | -2 | |
| Tax % | -0.00% | 0.00% | 5.00% | 0.00% | -0.00% | 0.00% | 0.00% | 11.92% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% |
| Net Profit | 0 | 0 | 0 | 0 | -24 | -40 | -46 | -15 | 96 | 80 | 55 | 15 | -2 |
| -2 | -1 | -2 | -4 | -1 | -2 | -1 | -1 | 3 | 3 | 2 | 1 | -0 | |
| Equity Capital | 25 | 26 | 26 | 26 | 26 | 26 | 26 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 25 | 26 | 26 | 26 | 26 | 26 | 26 | 29 | 29 | 29 | 29 | 29 | 29 |
| Reserves | 49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 16
- 16
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -1
- Tax %
- -0.00%
- Net Profit
- 0
- -2
- Equity Capital
- 25
- Reserves
- 49
- Promoter Pledge %
- 0.00%
- Equity Capital
- 25
- Reserves
- 49
- Promoter Pledge %
- 0.00%
Sep 2023
- 24
- 23
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 0
- -1
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 22
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 5.00%
- Net Profit
- 0
- -2
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 18
- 17
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 0.00%
- Net Profit
- 0
- -4
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 18
- 18
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- -0.00%
- Net Profit
- -24
- -1
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 21
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- -40
- -2
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 21
- 19
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- -46
- -1
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 26
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 23
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 11.92%
- Net Profit
- -15
- -1
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 26
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 3
- Tax %
- 0.00%
- Net Profit
- 96
- 3
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 23
- 21
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 2
- Tax %
- 0.00%
- Net Profit
- 80
- 3
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 17
- 16
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 0
- Tax %
- 0.00%
- Net Profit
- 55
- 2
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 20
- 20
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- 1
- Tax %
- 0.00%
- Net Profit
- 15
- 1
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 23
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -2
- Tax %
- -0.00%
- Net Profit
- -2
- -0
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| 77 | 91 | 63 | 79 | 83 | 86 | 83 | |
| 77 | 105 | 90 | 76 | 81 | 79 | 78 | |
| Operating Profit | 1 | -13 | -26 | 4 | 6 | 8 | — |
| OPM % | 2 | -15 | -41 | 5 | 7 | 10 | — |
| Other Income | 1 | 1 | 0 | 1 | 4 | 1 | 1 |
| Interest | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 2 | 2 | 2 | 2 |
| -9 | -24 | -38 | -20 | -10 | 25 | 1 | |
| Tax % | -115 | 19 | 19 | -0 | -2 | 0 | 0 |
| Net Profit | -19 | -19 | -31 | -20 | -10 | 25 | 1 |
| EPS | -7 | -8 | -13 | -7 | -3 | 8 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 8 | 10 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Adjusted EPS | -8 | -5 | -8 | -7 | -3 | 8 | — |
| Minority Interest | 0 | 8 | 10 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Adjusted EPS | -8 | -5 | -8 | -7 | -3 | 8 | — |
Mar 2021
- 77
- 77
- Operating Profit
- 1
- OPM %
- 2
- Other Income
- 1
- Interest
- 3
- Depreciation
- 7
- -9
- Tax %
- -115
- Net Profit
- -19
- EPS
- -7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2022
- 91
- 105
- Operating Profit
- -13
- OPM %
- -15
- Other Income
- 1
- Interest
- 3
- Depreciation
- 7
- -24
- Tax %
- 19
- Net Profit
- -19
- EPS
- -8
- Dividend Payout %
- 0
- Minority Interest
- 8
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 8
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2023
- 63
- 90
- Operating Profit
- -26
- OPM %
- -41
- Other Income
- 0
- Interest
- 2
- Depreciation
- 7
- -38
- Tax %
- 19
- Net Profit
- -31
- EPS
- -13
- Dividend Payout %
- 0
- Minority Interest
- 10
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 10
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2024
- 79
- 76
- Operating Profit
- 4
- OPM %
- 5
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- -20
- Tax %
- -0
- Net Profit
- -20
- EPS
- -7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -7
Mar 2025
- 83
- 81
- Operating Profit
- 6
- OPM %
- 7
- Other Income
- 4
- Interest
- 1
- Depreciation
- 2
- -10
- Tax %
- -2
- Net Profit
- -10
- EPS
- -3
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -3
Mar 2026
- 86
- 79
- Operating Profit
- 8
- OPM %
- 10
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 25
- Tax %
- 0
- Net Profit
- 25
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
TTM
- 83
- 78
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 1
- Depreciation
- 2
- 1
- Tax %
- 0
- Net Profit
- 1
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 9
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 9
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 2%
- 3 Years:
- 11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- -4%
- 5 Years:
- -12%
- 3 Years:
- -16%
- 1 Year:
- -60%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- -16%
- 3 Years:
- -6%
- Last Year:
- 22%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - |
| Equity Capital | 25 | 25 | 25 | 26 | 29 | 29 |
| 54 | 63 | 49 | 39 | 69 | 93 | |
| 17 | 15 | 6 | 5 | 6 | 6 | |
| Trade Payables | 31 | 28 | 23 | 15 | 14 | 11 |
| 35 | 64 | 7 | 4 | 6 | 8 | |
| Total Liabilities | 162 | 195 | 110 | 90 | 124 | 148 |
| ASSETS | - | - | - | - | - | - |
| 108 | 110 | 15 | 14 | 14 | 15 | |
| Capital Work in Progress | 1 | 15 | 0 | 0 | 0 | 1 |
| 0 | 0 | 64 | 43 | 74 | 92 | |
| 24 | 28 | 11 | 10 | 9 | 11 | |
| 0 | 0 | 0 | 16 | 20 | 16 | |
| Cash & Bank | 2 | 4 | 1 | 1 | 1 | 8 |
| 29 | 38 | 18 | 7 | 6 | 5 | |
| Total Assets | 162 | 195 | 110 | 90 | 124 | 148 |
| Total Debt | 31 | 24 | 6 | 5 | 6 | 7 |
| Net Working Capital | -16 | 12 | -5 | 8 | 11 | 16 |
| Contingent Liabilities | 7 | 24 | 20 | 71 | 76 | 123 |
| Book Value per Share | 32.04 | 35.42 | 29.94 | 24.99 | 33.30 | 41.64 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 31 | 24 | 6 | 5 | 6 | 7 |
| Net Working Capital | -16 | 12 | -5 | 8 | 11 | 16 |
| Contingent Liabilities | 7 | 24 | 20 | 71 | 76 | 123 |
| Book Value per Share | 32.04 | 35.42 | 29.94 | 24.99 | 33.30 | 41.64 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2021
- Equity Capital
- 25
- 54
- 17
- Trade Payables
- 31
- 35
- Total Liabilities
- 162
- 108
- Capital Work in Progress
- 1
- 0
- 24
- 0
- Cash & Bank
- 2
- 29
- Total Assets
- 162
- Total Debt
- 31
- Net Working Capital
- -16
- Contingent Liabilities
- 7
- Book Value per Share
- 32.04
- Face Value
- 10.00
- Total Debt
- 31
- Net Working Capital
- -16
- Contingent Liabilities
- 7
- Book Value per Share
- 32.04
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 25
- 63
- 15
- Trade Payables
- 28
- 64
- Total Liabilities
- 195
- 110
- Capital Work in Progress
- 15
- 0
- 28
- 0
- Cash & Bank
- 4
- 38
- Total Assets
- 195
- Total Debt
- 24
- Net Working Capital
- 12
- Contingent Liabilities
- 24
- Book Value per Share
- 35.42
- Face Value
- 10.00
- Total Debt
- 24
- Net Working Capital
- 12
- Contingent Liabilities
- 24
- Book Value per Share
- 35.42
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 25
- 49
- 6
- Trade Payables
- 23
- 7
- Total Liabilities
- 110
- 15
- Capital Work in Progress
- 0
- 64
- 11
- 0
- Cash & Bank
- 1
- 18
- Total Assets
- 110
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 20
- Book Value per Share
- 29.94
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- -5
- Contingent Liabilities
- 20
- Book Value per Share
- 29.94
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 26
- 39
- 5
- Trade Payables
- 15
- 4
- Total Liabilities
- 90
- 14
- Capital Work in Progress
- 0
- 43
- 10
- 16
- Cash & Bank
- 1
- 7
- Total Assets
- 90
- Total Debt
- 5
- Net Working Capital
- 8
- Contingent Liabilities
- 71
- Book Value per Share
- 24.99
- Face Value
- 10.00
- Total Debt
- 5
- Net Working Capital
- 8
- Contingent Liabilities
- 71
- Book Value per Share
- 24.99
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 29
- 69
- 6
- Trade Payables
- 14
- 6
- Total Liabilities
- 124
- 14
- Capital Work in Progress
- 0
- 74
- 9
- 20
- Cash & Bank
- 1
- 6
- Total Assets
- 124
- Total Debt
- 6
- Net Working Capital
- 11
- Contingent Liabilities
- 76
- Book Value per Share
- 33.30
- Face Value
- 10.00
- Total Debt
- 6
- Net Working Capital
- 11
- Contingent Liabilities
- 76
- Book Value per Share
- 33.30
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 29
- 93
- 6
- Trade Payables
- 11
- 8
- Total Liabilities
- 148
- 15
- Capital Work in Progress
- 1
- 92
- 11
- 16
- Cash & Bank
- 8
- 5
- Total Assets
- 148
- Total Debt
- 7
- Net Working Capital
- 16
- Contingent Liabilities
- 123
- Book Value per Share
- 41.64
- Face Value
- 10.00
- Total Debt
- 7
- Net Working Capital
- 16
- Contingent Liabilities
- 123
- Book Value per Share
- 41.64
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| 4 | -37 | -14 | -10 | 3 | 9 | |
| Cash from Investing | -5 | -25 | 0 | 0 | -45 | -3 |
| Cash from Financing | 1 | 64 | 11 | 10 | 42 | 0 |
| 0 | 2 | -3 | 0 | -0 | 7 | |
| Free Cash Flow | 4 | -61 | -14 | -10 | 1 | 7 |
| OCF / Net Profit | -0.23 | 1.94 | 0.47 | 0.50 | -0.26 | 0.38 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -78 |
| OCF / Net Profit | -0.23 | 1.94 | 0.47 | 0.50 | -0.26 | 0.38 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -78 |
Mar 2021
- 4
- Cash from Investing
- -5
- Cash from Financing
- 1
- 0
- Free Cash Flow
- 4
- OCF / Net Profit
- -0.23
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.23
- Cumulative 5-Year FCF
- 0
Mar 2022
- -37
- Cash from Investing
- -25
- Cash from Financing
- 64
- 2
- Free Cash Flow
- -61
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- 0
Mar 2023
- -14
- Cash from Investing
- 0
- Cash from Financing
- 11
- -3
- Free Cash Flow
- -14
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.47
- Cumulative 5-Year FCF
- 0
Mar 2024
- -10
- Cash from Investing
- 0
- Cash from Financing
- 10
- 0
- Free Cash Flow
- -10
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.50
- Cumulative 5-Year FCF
- 0
Mar 2025
- 3
- Cash from Investing
- -45
- Cash from Financing
- 42
- -0
- Free Cash Flow
- 1
- OCF / Net Profit
- -0.26
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.26
- Cumulative 5-Year FCF
- 0
Mar 2026
- 9
- Cash from Investing
- -3
- Cash from Financing
- 0
- 7
- Free Cash Flow
- 7
- OCF / Net Profit
- 0.38
- Cumulative 5-Year FCF
- -78
- OCF / Net Profit
- 0.38
- Cumulative 5-Year FCF
- -78
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - |
| EPS (₹) | -7.84 | -4.57 | -8.46 | -7.46 | -3.38 | 8.35 |
| Book Value (₹) | 32.04 | 35.42 | 29.94 | 24.99 | 33.30 | 41.64 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | -4.90 | -4.80 | -9.63 | -6.79 | -2.84 | 8.89 |
| PROFITABILITY | - | - | - | - | - | - |
| Operating Margin % | 1.63% | -14.75% | -41.46% | 3.85% | 1.62% | 8.23% |
| Net Margin % | -25.08% | -21.18% | -49.12% | -24.65% | -12.07% | 28.67% |
| ROE % | -24.48% | -23.18% | -38.46% | -28.08% | -12.18% | 22.27% |
| ROCE % | -5.33% | -18.72% | -37.83% | -24.92% | -10.03% | 21.72% |
| -11.95% | -10.83% | -20.41% | -19.59% | -9.31% | 18.08% | |
| EFFICIENCY | - | - | - | - | - | - |
| Debtor Days | 65 | 63 | 88 | 67 | 80 | 77 |
| Inventory Days | 112 | 102 | 112 | 48 | 42 | 43 |
| Payable Days | 237 | 171 | 185 | 125 | 98 | 90 |
| -61 | -6 | 15 | -10 | 24 | 30 | |
| FINANCIAL HEALTH | - | - | - | - | - | - |
| Debt to Equity (x) | 0.40x | 0.28x | 0.08x | 0.08x | 0.06x | 0.06x |
| Interest Coverage (x) | -1.90x | -6.72x | -16.58x | -22.16x | -8.52x | 30.43x |
| 0.74x | 1.25x | 0.84x | 1.35x | 1.48x | 1.72x | |
| GROWTH | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 18.04% | -30.69% | 25.76% | 3.86% | 3.85% |
| Operating Profit Growth % | 0.00% | -1170.52% | -94.85% | 115.92% | 39.52% | 41.36% |
| Net Profit Growth % | 0.00% | 0.33% | -60.76% | 36.90% | 49.13% | 346.65% |
| 0.00% | 0.00% | 0.00% | 11.74% | 54.67% | 346.65% | |
| VALUATION | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 4.49x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 3.71x | 3.23x | 0.90x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 59.41x | 55.34x | 13.39x |
Mar 2021
- EPS (₹)
- -7.84
- Book Value (₹)
- 32.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -4.90
- Operating Margin %
- 1.63%
- Net Margin %
- -25.08%
- ROE %
- -24.48%
- ROCE %
- -5.33%
- -11.95%
- Debtor Days
- 65
- Inventory Days
- 112
- Payable Days
- 237
- -61
- Debt to Equity (x)
- 0.40x
- Interest Coverage (x)
- -1.90x
- 0.74x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -4.57
- Book Value (₹)
- 35.42
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -4.80
- Operating Margin %
- -14.75%
- Net Margin %
- -21.18%
- ROE %
- -23.18%
- ROCE %
- -18.72%
- -10.83%
- Debtor Days
- 63
- Inventory Days
- 102
- Payable Days
- 171
- -6
- Debt to Equity (x)
- 0.28x
- Interest Coverage (x)
- -6.72x
- 1.25x
- Revenue Growth %
- 18.04%
- Operating Profit Growth %
- -1170.52%
- Net Profit Growth %
- 0.33%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -8.46
- Book Value (₹)
- 29.94
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -9.63
- Operating Margin %
- -41.46%
- Net Margin %
- -49.12%
- ROE %
- -38.46%
- ROCE %
- -37.83%
- -20.41%
- Debtor Days
- 88
- Inventory Days
- 112
- Payable Days
- 185
- 15
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- -16.58x
- 0.84x
- Revenue Growth %
- -30.69%
- Operating Profit Growth %
- -94.85%
- Net Profit Growth %
- -60.76%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -7.46
- Book Value (₹)
- 24.99
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -6.79
- Operating Margin %
- 3.85%
- Net Margin %
- -24.65%
- ROE %
- -28.08%
- ROCE %
- -24.92%
- -19.59%
- Debtor Days
- 67
- Inventory Days
- 48
- Payable Days
- 125
- -10
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- -22.16x
- 1.35x
- Revenue Growth %
- 25.76%
- Operating Profit Growth %
- 115.92%
- Net Profit Growth %
- 36.90%
- 11.74%
- P/E (x)
- 0.00x
- P/B (x)
- 3.71x
- Dividend Yield %
- 0.00%
- 59.41x
Mar 2025
- EPS (₹)
- -3.38
- Book Value (₹)
- 33.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -2.84
- Operating Margin %
- 1.62%
- Net Margin %
- -12.07%
- ROE %
- -12.18%
- ROCE %
- -10.03%
- -9.31%
- Debtor Days
- 80
- Inventory Days
- 42
- Payable Days
- 98
- 24
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- -8.52x
- 1.48x
- Revenue Growth %
- 3.86%
- Operating Profit Growth %
- 39.52%
- Net Profit Growth %
- 49.13%
- 54.67%
- P/E (x)
- 0.00x
- P/B (x)
- 3.23x
- Dividend Yield %
- 0.00%
- 55.34x
Mar 2026
- EPS (₹)
- 8.35
- Book Value (₹)
- 41.64
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.89
- Operating Margin %
- 8.23%
- Net Margin %
- 28.67%
- ROE %
- 22.27%
- ROCE %
- 21.72%
- 18.08%
- Debtor Days
- 77
- Inventory Days
- 43
- Payable Days
- 90
- 30
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 30.43x
- 1.72x
- Revenue Growth %
- 3.85%
- Operating Profit Growth %
- 41.36%
- Net Profit Growth %
- 346.65%
- 346.65%
- P/E (x)
- 4.49x
- P/B (x)
- 0.90x
- Dividend Yield %
- 0.00%
- 13.39x
Documents
Announcements
- Updates
2026-08-17 - Brooks Laboratories Limited has informed the Exchange regarding 'Intimation Of Record Date, E-Voting Dates And Book Closure Date'.
- Copy of Newspaper Publication
2026-08-14 - Brooks Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nothing filed yet.